
Rx Required
Tirzepatide
Compounded Tirzepatide. Prepared by a licensed 503A/503B pharmacy. Dual-action GIP/GLP-1 agonist targeting two hormone pathways for stronger appetite suppression and greater weight reduction.
Get Started →
One pathway wasn't enough.
So we target two.
Tirzepatide is a dual GIP/GLP-1 receptor agonist that works on two hormone pathways simultaneously. It suppresses appetite, reduces food noise, improves insulin sensitivity, and may produce stronger weight reduction than single-pathway GLP-1 medications alone.
Compounded by a licensed 503A/503B facility. Your dosing protocol is tailored to your history, tolerance, and goals through our async telehealth model. One weekly injection. No membership. No subscription.
Two pathways. One protocol.
Dual Hormone Action
Targets both GIP and GLP-1 receptors simultaneously. Two metabolic pathways working together for stronger, more comprehensive appetite control.
Greater Weight Reduction
Clinical trials show 20-25% average body weight reduction. The dual-agonist mechanism may outperform single-pathway GLP-1 medications.
Metabolic Optimization
Enhanced insulin sensitivity and glucose regulation through two distinct receptor pathways. Your metabolism recalibrates at a deeper level.
Food Noise Elimination
The constant mental chatter about food goes quiet. Not willpower. Not discipline. Biology, corrected on two fronts.
Cardiovascular Support
Emerging data supports cardiovascular benefits including improved lipid profiles and reduced inflammatory markers alongside weight reduction.
Your body responds.
How it works.
Already on GLP-1s?
We accept clients at any dose. Transfer your protocol to IVUSE+ and continue without interruption.
Proof of prior treatment required.
Refill Request →Your clinician reads every intake.
What you should know before starting.
Review the complete safety profile, contraindications, and clinical guidance before beginning your protocol. Your prescribing clinician will review this with you during your consultation.
Read Full Safety Information →Your Protocol Starts Here.
Compounded Tirzepatide. Dual-action dosing. No membership, no subscription. Flat rate, every refill.
Get Started →Individual results vary. Compounded medications are not FDA-approved but contain FDA-approved active ingredients. A telehealth consultation with a licensed clinician is required before any prescription is issued. IVUSE+ does not guarantee specific weight loss outcomes. Medication is compounded by a licensed 503A/503B compounding facility.
